Today: 30 June 2026

Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation.

2025 Porsche 911 S/T: Legend Reborn – The Ultimate Analog 911 Driving Machine

Porsche Crashes: 96% Profit Plunge Triggers €1B Quarterly Loss – What’s Next?

Why Profits Cratered: Apart from tariffs, Porsche cited a sudden about-face on its EV strategy. In September the company scaled back its electrification plan, shelving plans for a proprietary battery factory and slowing EV projects. These moves triggered one-time charges and raised doubt about future growth. CEO Blume had to admit that Porsche’s “shift to electric vehicles” is slowing, at a time when rivals are racing aheadreuters.com. At the same time, luxury buyers in China – a key market – are tightening their belts; CFO Breckner noted “general market conditions will not improve in the foreseeable future”reuters.com. Leader’s Take: CFO Breckner struck a cautiously hopeful tone. He said that 2025 should mark the bottom of the cycle, with profits set to bounce back in 2026. “We expect 2025 to be the trough that precedes a noticeable improvement for Porsche from 2026 onwards,” he told analystsreuters.com. Porsche is even holding firm to its full-year guidance: it still predicts up to ~2% return on sales in 2025, down from 14% in 2024reuters.com. Breckner also warned that proposed U.S. price hikes would lift U.S. sales prices in coming months, and that the 2025 dividend will be “significantly” lower than the €2.31 paid last
24 October 2025
·
OpenAI Unveils ChatGPT Atlas Browser — Google Shares Tumble in AI Search Showdown

OpenAI’s ChatGPT Atlas Browser Takes on Chrome – Privacy Alarm and Stock Market Whiplash

In-depth report: ChatGPT Atlas is not just a regular browser with an AI tacked on – it is built around ChatGPT.techradar.com At launch it’s essentially a Chromium-based browser where every tab can become an interactive conversation. OpenAI describes it as a “super-assistant” that understands your goals and context, auto-prompting actions without copy-pasteopenai.comtechradar.com. In practice, this means Atlas replaces Google Search with ChatGPT’s engine, adding a chat pane to web pages for summaries, rewriting tasks, or deeper analysiswashingtonpost.comtechradar.com.
24 October 2025
··
Gundremmingen Cooling Towers Implode – Who Wins & Loses on Energy Stocks?

Gundremmingen Cooling Towers Implode – Who Wins & Loses on Energy Stocks?

Key Facts: On Oct 25, 2025 at 12:00, Germany will detonate the two 160 m cooling towers of the former Gundremmingen nuclear plant in Bavariasueddeutsche.de. In a matter of seconds the 56,000 tons of reinforced concrete will collapse and be recycled as aggregatesueddeutsche.de. A large exclusion zone surrounds the sitesueddeutsche.de. About 10,000 spectators are expectedmerkur.demerkur.de. Engineers have cut structural slots and will trigger water-jet fountains to force the towers to collapse inward and bind dustmerkur.de. Gundremmingen was one of Germany’s first atomic power sites, so the implosion is seen as a symbolic end to the nuclear age in Bavariamerkur.de. RWE – the plant’s former operator – will immediately begin converting the site to renewables: four days post-blast it will break ground on what it calls “Germany’s largest” battery storage project to save solar energyfocus.de. In-depth: The scheduled controlled demolition has captured public attention. Authorities have issued a full safety cordon, with road closures and parking bans in nearby Gundremmingen. District officials warn of “massive traffic congestion” and urge the public to arrive early or watch from remote vantage pointsgundremmingen.degundremmingen.de. Mayor Tobias Bühler notes that “with the towers’ demolition we lose a piece of our home – even for me personally”gundremmingen.de,
24 October 2025
·
IBM Stock Soars on Quantum Breakthrough and AI Revival – Key Updates (Sept 25, 2025)

Quantum Surprise: IBM Runs 10× Faster Error‐Correction on AMD Chips, Stocks Skyrocket

IBM and AMD are aggressively combining their strengths in quantum and classical computing. In August 2025 they announced a “quantum‑centric supercomputing” alliance, aiming to blend IBM’s quantum chips with AMD’s CPUs, GPUs and FPGAsamd.comamd.com. As IBM CEO Arvind Krishna put it, “Quantum computing will simulate the natural world and represent information in an entirely new way… [working] together… we will build a powerful hybrid model that pushes past the limits of traditional computing.”amd.com AMD’s CEO Lisa Su echoed this vision: by converging high‑performance and quantum computing, “we see tremendous opportunities to accelerate discovery and innovation.”amd.com The October announcement is a concrete step in that plan. IBM published research showing its quantum error‑correction algorithm – developed in June – can run in real time on an off‑the‑shelf AMD field‑programmable gate arrayreuters.com. This matters because qubits are extremely error‑prone. Real‑time error correction is critical for fault‑tolerant quantum machines. As IBM’s Gambetta explained, the fact that the algorithm works on a “readily available AMD chip that is not ‘ridiculously expensive’” is a breakthroughreuters.com. AMD’s role is crucial: its chips could provide the fast, parallel processing needed to correct qubit errors on the flyamd.com.
24 October 2025
···
Gold Price Surges Past $3,800; Silver Nears 14-Year High on Fed-Cut and Shutdown Fears

Gold Blasts Above $4,100; Silver Sizzles on Fed-Cut Hopes

Key Facts: Gold traded around $4,118/oz on Oct. 24, 2025, near its all-time highpricegold.net. Silver was about $48.7/oz at the same timebullion-rates.com. Both metals plunged sharply earlier this week – on Oct. 21 gold dropped ~6.3% to ~$4,082 and silver fell ~8.7% to ~$47.89, marking their largest one-day losses since 2013 and 2021 respectivelybusinesstoday.in. Investors now brace for a Federal Reserve rate cut even as central banks around the world continue buying goldmarkets.financialcontent.commarkets.financialcontent.com. Gold mining and precious-metal ETFs have outperformed stocks – e.g. the VanEck Gold Miners ETF is up ~123% year-to-dateonedayadvisor.com – suggesting “super-cycle” strength in the metals sectoronedayadvisor.commarkets.financialcontent.com. On Friday Oct. 24, 2025, gold prices held near record highs after a volatile week of trading. Spot gold was about $4,118 per troy ounce, slightly below this week’s intraday peak, while silver traded near $48.7/ozpricegold.netbullion-rates.com. In euros, these levels translate roughly to €3,530/oz for gold and €41.7/oz for silverbullion-rates.combullion-rates.com. Over the past few days gold dipped from around $4,356 on Oct. 20 to the low $4,080s on Oct. 21, then recovered modestly to $4,118 by the 24thpricegold.netbusinesstoday.in. Silver saw a similar pattern – peaking above $54 in mid-October, crashing to the high $47s on Oct. 21, and then rebounding
24 October 2025
··
Stock Market on Edge: U.S. Futures Slide as US-China Trade War Heats Up

Stocks Surge on Cooling Inflation – Fed Cuts Loom, Experts Warn of Bubble

U.S. equities roared higher as fresh data showed inflation easing, boosting hopes of cheaper borrowing costs. The Labor Department’s Sept. CPI report showed prices up only 3.0% year-on-year – just shy of expectationsts2.tech. Traders seized on the news: stock futures jumped and all three major indexes closed higher on Oct. 23ts2.tech. “Equities are enjoying a broadly supportive environment,” said Peter Fitzgerald, macro CIO at Aviva Investorsts2.tech, reflecting optimism that Fed easing is coming. In practical terms, the S&P 500 and Nasdaq Composite are trading near record levelsts2.tech, with year-to-date gains of ~15–18%. Tech giants and semiconductor makers powered the move. Tesla rebounded on strong earnings, and chipmakers surged on AI demand. In fact, Nvidia is up ~41% so far this year and Palantir an astonishing 143%ts2.tech, as investors pile into stocks tied to artificial intelligence. Broadcom hit multi-year highs after unveiling a $10 billion AI-chip deal with OpenAIts2.tech. Major “Magnificent Seven” names like Apple and Microsoft also remain “broadly bid” in the rallyts2.tech. Commodities moved: oil surged on new supply sanctions, and gold gave back a bit from its recent record, but the focus was on tech-led gains.
24 October 2025
········
Broadcom’s AI Windfall: Inside AVGO’s Trillion-Dollar Surge, $10B Chip Deal & 2025 Outlook

Broadcom (AVGO) Stock Skyrockets on $10B OpenAI AI Chip Deal — Are $450 Targets Next?

Broadcom’s stock has soared in recent days as the chipmaker emerges as a central player in the booming AI industry. On Friday, Oct. 24, the shares were trading in the mid-$350s – about double their level a year earlier – and were up around 3–4% on the dayinvesting.com. The recent jump follows a series of bullish developments for AVGO. Notably, Broadcom announced an $10 billion AI chip deal with OpenAI on Oct. 13. Under this partnership, Broadcom will co-design 10 gigawatts of custom AI accelerator chips for OpenAI over the next few yearsts2.tech. Investors cheered the news: the stock spiked roughly 10% on the day of the announcementts2.tech. OpenAI’s CEO Sam Altman praised the tie-up as “a critical step in building the infrastructure needed to unlock AI’s potential”ts2.tech, highlighting the deal’s importance to AI data-center expansion. Broadcom also introduced new products for AI in mid-October, further boosting confidence in its AI roadmapts2.tech. The earnings picture has been just as bright. In early September, Broadcom reported blockbuster Q3 results. Revenue jumped 22% year-over-year to $15.95 billion, beating Wall Street estimatests2.tech. Remarkably, Broadcom turned that revenue into about $7.0 billion of free cash flowts2.tech – a record margin reflecting strong demand for
24 October 2025
··
Amazon Stock Today: AI Ambitions, $2.5B Twist, and $3 Trillion Dreams

Amazon (AMZN) Stock Skyrockets on AI Push & Legal Win – Analysts See $300+ Target Ahead

After peaking near $242 in Feb 2025, Amazon’s stock has been under pressure. A tech sell-off in late Q2 and some profit-taking pulled AMZN down into the low-$210s over summer. By mid-October it recovered to the mid-$210sts2.tech. Its recent bounce was supported by key technical levelsts2.techts2.tech. As of Oct 24, Amazon is trading around $224reuters.com. The day’s trading volume was below summer peaks, but notable moves on news-driven days. Overall, AMZN’s price is currently about 7–10% below its all-time high of $242ts2.tech, and roughly flat year-to-datets2.techts2.tech. In contrast, the Nasdaq and stocks like Apple and Microsoft have rallied ~20% this yearts2.tech. This relative underperformance has left some analysts calling Amazon a “discounted” stock, while others point to lingering high valuation as a caution. Wall Street analysts remain overwhelmingly bullish on AMZN despite the tepid share gains this year. Research firm TS2.tech reports that “nearly all analysts rate AMZN a ‘Buy’,” with average 12-month targets in the high-$260sts2.techts2.tech. Goldman Sachs recently reaffirmed Amazon as a “Top Pick,” boosting its target to $275 and citing underappreciated strength in the cloud and ad businessests2.tech. In late September, Wells Fargo upgraded AMZN to Overweight with a $280 targetts2.tech. Benchmark’s Daniel Kurnos and Telsey’s Joseph
24 October 2025
Oracle’s ‘Truly Awesome’ AI Cloud Quarter Sends Stock Soaring 36%, Making Ellison World’s Richest

Oracle (ORCL) Stock Surges on AI Frenzy – Trillion-Dollar Dreams in Focus

Oracle’s stock price has been volatile but trending up. On Oct. 24, 2025, ORCL traded in the $282.80–$287.19 range and closed at $285.72economictimes.indiatimes.com. Volume was heavyeconomictimes.indiatimes.com. This follows a mid-October swing: a sharp selloff on Oct. 22 was quickly bought back, with the stock rebounding to close $281.31 on Oct. 23historicaloptiondata.com. Technical data show ORCL bouncing off its 50-day moving average near $274, though still below the 20-day meanhistoricaloptiondata.com. The stock’s year-to-date rise is dramatic: ORCL hit a record ~$345 intraday in early September 2025ts2.tech, up roughly +75% from January levelsts2.techts2.tech. That peak came after news of multi-hundred-billion-dollar AI contracts. After profit-taking, ORCL pulled back to the high-$200s, but even at ~$285 it is well above its year-ago pricets2.techts2.tech. Tech analysts note this surge “left even the ‘Magnificent Seven’ tech stocks trailing” in 2025ts2.tech.
24 October 2025
···
Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple (AAPL) Stock Rockets to Record High on iPhone 17 Hype — What’s Next?

Apple shares have been volatile but are trading very near record levels. On Oct. 20, investors bid the stock up sharply – by the close it was ~$262ts2.tech. Since then the stock has pulled back a bit to the high-$250s. By the end of Oct. 23, AAPL was around $259.58marketbeat.com. For context, Apple’s stock is up only a few percent in 2025, far less than peer tech giants. That modest gain reflects Apple’s already lofty valuation. Technically, Apple has shown resilience. A brief sell-off on Oct. 14 saw AAPL dip early but ultimately close flatts2.tech. Traders noted that the stock held above key moving averages, indicating positive momentum going into this weekts2.tech. If the stock can hold around the $260 level, bulls argue it could have room to run.
24 October 2025
···
NV Energy Stock Holds Steady Amid Nevada Utility Turmoil

NV Energy Stock Holds Steady Amid Nevada Utility Turmoil

NV Energy’s stock is essentially flat this week, closing at $23.74 per share on Oct. 24, 2025investing.cominvesting.com. The share price is right at its recent range and no new 52-week high or low is indicatedinvesting.com. In fact, the investing.com data shows zero price change on the latest quoteinvesting.com. Trading volume is negligible, and the 3-month average volume is only about 1.76 million shares per dayinvesting.com. MarketBeat explicitly warns that NVE has been “marked as potentially delisted” and may not be actively tradingmarketbeat.com. In practice, this means NV Energy stock behaves more like a very thinly traded utility issue than a busy market ticker. The lack of movement means there is no clear trend in the stock price. Over longer periods, NVE has been roughly flat. Investing.com notes the 1-year change is 0%investing.com, indicating the price has held steady around the mid-$20s for months. In sum, as of Oct. 24, NV Energy stock is not undergoing any dramatic rally or crash – instead it’s paused amid the ongoing regulatory and policy news in Nevada and Washington.
24 October 2025
·
Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr’s stock price skyrocketed after news of a potential insider buyout broke. On Friday, Oct. 24, GRND opened at $14.50 and surged as high as $16.22 intraday, an approximately 25% jump from the prior day’s closeinvesting.com. The rally came after Grindr confirmed that its two largest shareholders – board Chair James Fu Bin Lu and director G. Raymond Zage III – had submitted a preliminary proposal to take the company private at $18.00 per share in cashd18rn0p25nwr6d.cloudfront.netd18rn0p25nwr6d.cloudfront.net. By the end of the day, Grindr stock was hovering around $15.90 on heavy volumebarchart.com, as investors digested the possibility of a buyout. This dramatic one-day gain reversed what had been a steep downward trend for Grindr’s shares over the past several months. Prior to the buyout buzz, GRND was down roughly 20–30% in 2025tipranks.combarchart.com, trading near all-time lows. In fact, the stock had languished around the $12 range this month, not far above its 52-week low of ~$11.73investing.com. The sudden takeover interest injected new optimism into the market’s view of Grindr. Traders immediately bid up the price toward the rumored deal level, betting that the offer could materialize and deliver a quick payoff.
24 October 2025
··
Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz

Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz

Stock Performance: Clover Health stock has been exceptionally volatile in mid‑October 2025. On Oct. 21 it jumped ~8.7% intraday to ~$3.20 Marketbeat, and on Oct. 24 it spiked another ~18%, trading near $3.79 Reuters. According to Reuters data, that surge propelled CLOV close to its 52-week high and far above its recent 50‑day moving average Marketbeat. The 200-day average was also eclipsed, signaling strong upward momentum Marketbeat. This rally has come on unusually heavy volume Reuters, reflecting frenzied buying. By contrast, the stock was languishing near multi-year lows just a few months ago, underscoring the swing. Overall, CLOV’s high beta and large short interest mean it tends to move sharply on news and market sentiment Marketbeat Fintel. Analyst Views: Wall Street opinions on CLOV remain split. Last week Zacks Research upgraded Clover to a #2 rank, noting that upward revisions in earnings estimates tend to propel stock gains Finviz. MarketBeat reports that Canaccord Genuity cut its target to $4.10 and UBS lowered its target to $3.00 in early October Marketbeat. Two analysts have Buy ratings and two have Hold Marketbeat, yielding a consensus “Hold” stance. The five‑analyst average price target is about $4.03 Marketbeat, slightly above current levels. Notably, Weiss
24 October 2025
·
Western Union Stock Edges Up on Q3 Beat – CEO Calls Crypto an “Opportunity”

Western Union Stock Edges Up on Q3 Beat – CEO Calls Crypto an “Opportunity”

Investors will be watching WU’s short-term outlook as it delivers Q4 results and commentary. Wolfe notes management’s plan to stabilize its core retail business, re-accelerate digital growth, and diversify into new financial servicesinvesting.com. In the near term, stock momentum may hinge on whether retail volumes recover after a 2024 slump, and whether earnings forecasts hold up under higher interest costs. In the long term, Western Union’s global brand, broad agent network and high dividend yield could appeal to conservative investors if the company succeeds in its turnaround. “Our goal is to provide more and better solutions…to give our customers a superior experience,” said WU’s Latin America interim president Mauricio García of the dLocal partnershipbusinesswire.com. If Western Union can keep up with fintech innovations and manage costs, it could emerge as a yield play with room to grow digital payments. However, analysts warn that unproven digital initiatives and heavy competition mean the stock may tread water unless clear growth arrivesinvesting.cominvesting.com. Sources: Western Union Q3 press release and earnings reportbusinesswire.combusinesswire.com; Investing.com and MarketBeat stock reportsinvesting.commarketbeat.com; Reuters and BusinessWire newsts2.techbusinesswire.com; tech/crypto newsccn.comcoindesk.com; analyst reportsinvesting.cominvesting.combenzinga.com.
24 October 2025
··
Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics (TOVX) Stock Surges on Cancer Trial Breakthrough – What’s Next?

Theriva’s Stock Swing: In mid-October, Theriva’s Nasdaq-traded shares spiked on news of clinical success. On Oct. 15 the stock jumped from roughly $0.44 to $0.84 intradayts2.tech, an increase of about 92%. This surge coincided with reports that VCN-01 had met the primary endpoints in the VIRAGE Phase 2b trial. The very next trading day, Theriva disclosed a $4.0 million warrant inducement financing. Investors exercising warrants at $0.54 per share provided immediate cashts2.tech, but the announcement also trimmed the earlier stock rally – TOVX settled in the mid-$0.40 range by Oct. 16ts2.techts2.tech. In the days since, the stock has traded roughly between $0.28 and $0.35investing.com. As of Oct. 23 it closed around $0.2877investing.com, well below its 52-week high. This volatility reflects a classic biotech pattern: big moves on data and news, with technical trends still unsettled. Breakthrough Pancreatic Cancer Data: Theriva’s recent headlines stem from its oncolytic virus program. VCN-01 is an engineered adenovirus meant to infect and kill cancer cells while breaking down the tumor’s protective stromatherivabio.com. In May 2025, Theriva announced topline results from the VIRAGE trial showing that VCN-01 plus standard-of-care chemotherapy produced longer survival than chemo alonetherivabio.com. Specifically, patients on VCN-01 had a median overall survival of
24 October 2025
·
The $350B Shake-Up: How AI Summaries Rewire Publisher Traffic

Alphabet Stock Skyrockets to Record High, Nears $3 Trillion on AI Boom & Earnings Hype

Google’s headquarters campus in Mountain View. Alphabet’s stock has been on a tear, reaching all-time highs as investors cheer the company’s AI strides and strong financial performance. Alphabet’s stock is soaring into uncharted territory as of late October 2025. Shares of the Google parent company traded around $260–261 on Friday, flirting with the highest levels in its historystocktwits.com. Earlier this week, Alphabet hit an intraday peak just above $257 – marking a new record – and its latest surge has propelled the company’s market capitalization near the elite $3 trillion club alongside Apple and Microsoftts2.tech. Year to date, GOOG has climbed roughly 30%, a stellar run that far outpaces the broader market and even outperforms most of the “Magnificent 7” mega-cap tech stocksts2.tech. This rally accelerated in recent months amid a wave of enthusiasm for artificial intelligence initiatives across the tech sector.
24 October 2025
···
Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Key Facts: - Neuphoria shares plunged ~67% in after-hours trading on Oct 20 when its lead drug BNC210 failed a Phase 3 SAD trial Investing. The AFFIRM-1 trial missed both primary and secondary endpoints, and the company immediately halted its social anxiety program and launched a full strategic review Investing Globenewswire. - CEO Spyros Papapetropoulos vowed to “conserve our cash position” while exploring options to “maximize value for shareholders” Globenewswire. Neuphoria will evaluate BNC210 in PTSD and otherwise cut spending. - NEUP stock fell from about $15.40 on Oct 20 to roughly $5 in pre-market Oct 21 Investing Benzinga. By Oct 23 close it was ~$4.05 Reuters, then rebounded to ~$6.7 by Oct 24 Reuters Benzinga. - The company held $14.2M cash at June 30, 2025, projecting runway into mid‑2027 Globenewswire. It also maintains a Merck partnership worth up to $450M in milestones Globenewswire. - Analysts had been bullish, but many now question the SAD trial design. William Blair noted BNC210’s peak concentration arrives 2 hours after dosing, whereas the speech test came at 1 hour, possibly explaining the miss Biospace. Neuphoria’s blowout Phase 3 failure rocked investors this week. After market close on Oct. 20, the company announced that
24 October 2025
·
Picard Medical Stock Plummets 75% on Dilution Alert — What’s Driving the Crash?

Picard Medical Stock Plummets 75% on Dilution Alert — What’s Driving the Crash?

Picard Medical stock has been extremely volatile this month. After its Aug. 29 IPO at $4.00, PMI traded mostly under $10, but shot higher in mid-October. On Oct. 20 the stock closed around $11.60, then hit a new 52-week peak near $13.68 by Oct. 23stockanalysis.com. However, on Oct. 24 trading opened sharply lower. By mid-day Oct. 24 the shares were about $3.30, erasing nearly all the prior week’s gainsinvesting.com. Investing.com confirms that as of Oct. 24, 2025 PMI was trading at $3.27 with a previous close of $13.20investing.com. This represents a collapse of roughly 75% in just one day. Volume spiked as panic selling set in. Most reports point to one immediate trigger: an SEC 8-K filing on Oct. 14. That filing disclosed that Picard’s shareholders had approved a massive expansion of its 2021 Equity Incentive Planbenzinga.com. In effect, the company can now issue up to 18 million shares to employees and others. Such a jump in authorized shares raised alarms about future dilution of existing stock, and traders dumped the shares in response. Benzinga observed the stock “plunged approximately 65% in premarket trading” after the filing, erasing a recent bull runbenzinga.combenzinga.com.
24 October 2025
·
General Dynamics Stock Rockets to Record High on Blowout Q3 Results and Defense Windfall

General Dynamics Stock Rockets to Record High on Blowout Q3 Results and Defense Windfall

General Dynamics stunned investors on Oct. 24, 2025, with a blowout third-quarter report. The defense and aerospace giant said Q3 revenue was $12.91 billion – about 10.6% higher than a year ago – beating the ~$12.57 billion analysts expectedbenzinga.com. GAAP earnings per share came in at $3.88, well above the $3.69 consensus estimatebenzinga.combenzinga.com. Operating income was $1.3 billion, and margins expanded by 20 basis points to 10.3%. Management highlighted exceptionally strong demand. “Each of our four segments grew earnings and backlog in the quarter, reflecting solid execution coupled with growing demand,” CEO Phebe Novakovic saidbenzinga.com. In particular, GD’s Aerospace division had a banner quarter. Gulfstream delivered 39 business jets, up from 28 a year earlier, fueling a 30% jump in aerospace revenuereuters.com. Novakovic called the aerospace segment’s performance “impressive,” noting “very strong” order activity for luxury jetsreuters.com. The Marine Systems segment also grew revenue by double-digits, while its Combat Systems and Technologies units remained solid.
24 October 2025
···
NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

NeurAxis’s Oct. 24, 2025 announcement of FDA 510 clearance for its PENFS device immediately grabbed market attention. The clearance authorizes use in adults for functional abdominal pain associated with FD and nausea, a segment previously lacking any approved device treatmentinvesting.com. Investing.com and other outlets confirm this milestone — noting it’s “the first FDA clearance or approval” for an adult FD treatmentinvesting.com. In pre-market trading on Oct. 24, NRXS shares jumped on the news, reflecting relief that FDA evidence support could be extended to adultsinvesting.com. Management expects this expansion to “drive substantial top-line growth” as the therapy can now reach millions of adult patients along with children. At the same time, NeurAxis disclosed it raised its ATM offering cap. The 8-K filing shows the Craig-Hallum at-market facility was upped from $3.3M to $6.27M as of Oct. 23investing.com. No shares had been sold under the plan to date, but the larger capacity gives the company flexibility to raise capital into this growth phase. This comes after May 2025’s $5M equity saleglobenewswire.com, which CEO Carrico said, along with the new FDA clearance, “marks a significant milestone” and strengthens the balance sheet ahead of wider adoptionglobenewswire.com.
24 October 2025
··
1 … 249 250 251 252 253 … 397

Stock Market Today

  • Conagra Brands (CAG) Dividend Yield Tops 10% as Shares Fall
    June 29, 2026, 5:56 PM EDT. Conagra Brands Inc (CAG) stock briefly offered a yield above 10% Monday after the shares fell to $13.88. The yield uses the quarterly dividend, annualized at $1.40. Dividends make up a big part of investor returns, and historical numbers show payouts add to gains even when shares move around. Conagra is a major S&P 500 name with a high yield, but that payout could change depending on the company's profits. Investors may want to review Conagra's dividend track record to judge if this level is likely to hold.
Go toTop